coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Rossendale East PCN, Rossendale · Health Inequalities Profile

    PCN U81405 · NHS Lancashire and South Cumbria Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,418

    Registered population

    60.3% aged 18–64

    19.6%

    Aged 65+

    ICB 20.0% · England 17.9%

    6.4%

    Ethnic minority (non-White)

    4.3% Asian · England 9.6%

    40.8%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~13,060

    Core20 residents (est.)

    Resident basis; registered basis ~12,438 · see page 3

    5,729

    Hypertension register

    +6.45% in 3 yrs · England +5.60%

    325

    SMI register

    39.5% of Rossendale's

    1,000

    COPD register

    Reviews +8.34% in 3 yrs

    Forecast to 2030

    6,564

    Hypertension patients, 2030

    +835 on today

    66.0%

    QRISK ≥20% on statins, 2030

    +1.06pp over 3 yrs

    5.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -13.0%
    Dementia register fell while national prevalence grew.

    Recorded dementia prevalence fell 13.0% over 2023 to 2025 (England +6.0%) to 227 patients, which may reflect unverified coding or care-home case-finding gaps.

    70.5%
    Heart failure annual reviews trail all comparators.

    Annual heart failure functional reviews reached 70.5% of the 308-patient register (Rossendale 75.1%, ICB 78.9%, England 78.5%), which could reflect unverified recall gaps.

    61.6%
    Non-frail diabetes glycaemic control exceeds national average.

    HbA1c control in non-frail diabetes reached 61.6% (Rossendale 58.4%, ICB 56.2%, England 57.4%) after +18.4% three-year growth (England +4.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults make up 19.6% of patients, while ethnic minorities represent 6.4%

    Across 31,418 registered patients, ranging from 6,739 at Whitworth Medical Centre to 15,409 at Irwell Medical Practice, adults aged 65+ make up 19.6% (6,153 patients), compared with 17.6% in Rossendale, 20.0% in the ICB and 17.9% in England. Projected list growth to 2030 is 0.7% (Rossendale 1.2%, ICB 1.7%, England 2.3%; unverified method). Census resident estimates show 93.6% White ethnicity (Rossendale 92.4%, ICB 87.8%, England 81.1%), leaving a 6.4% ethnic minority share, and 4.3% Asian (Rossendale 5.5%, ICB 9.4%, England 9.6%). These resident bases do not represent registered patient ethnicity.

    Age profile

    0–1720.1%
    18–6460.3%
    65+19.6%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White93.6%
    Asian4.3%
    Mixed1.5%
    Other0.4%
    Black0.2%

    Older people · falls rows are Rossendale local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Rossendale LA)1,7992,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.3%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)61.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Rossendale LA)8391,0219552024/25
    Falls deaths, all ages, per 100,000 (Rossendale LA)12.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 40.8% across the PCN and varies sharply between practices

    Across the PCN, 40.8% of registered patients live in Core20 areas, above Rossendale (29.3%), the ICB (30.6%) and England (21.0%). Whitworth Medical Centre has a 0.0% Core20 share. Waterfoot Medical Practice has a 37.8% Core20 share (3,505 estimated patients). Irwell Medical Practice has a 58.0% Core20 share (8,933 estimated patients), creating a 58.0 pp practice range. Average IMD decile is 3.4. Weighted practice shares total 39.6%. Estimated Core20 patients are concentrated in Irwell Medical Practice and Waterfoot Medical Practice.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Irwell Medical58.0% · 8,933 patients
    Waterfoot Medical37.8% · 3,505 patients
    Whitworth0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    325

    SMI register

    1.03% recorded prevalence

    220

    Learning disability register

    0.70% recorded prevalence

    19

    Care homes, 463 beds

    In the PCN catchment

    9.3%

    Provide unpaid care

    Rossendale, Census 2021

    Recorded registers comprise 220 patients with learning disabilities (0.7% vs 0.6% in England) and 325 with severe mental illness (1.0%, matching England), alongside 463 care-home beds across 19 catchment sites. Borough unpaid carers (9.3%) and rough sleeping (0 in 2025) remain local-authority metrics.

    Severe mental illness: physical health checks

    On the 325-patient SMI register (1.0% prevalence), annual physical check completion trails England: blood pressure checks reached 78.7% (England 83.4%) and BMI recording reached 76.0% (England 82.1%). Dedicated recall could support physical health monitoring across both checks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,729

    Hypertension register

    +6.45%

    Register growth, 3 yrs

    Rossendale +7.87% · England +5.60%

    +2.66pp

    BP control, under 80

    ≤140/90 · +1.48pp aged 80+

    +835

    More patients by 2030

    Forecast 6,564 (20.56%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.1% (5,729 patients), above Rossendale (16.9%), the ICB (17.2%) and England (15.2%). Blood pressure treated to target reaches 71.1% (England 70.3%). However, recent blood pressure readings stand at 88.1% (England 90.0%), and under-80 control is 67.7% (England 67.8%), ranging from 58.5% at Whitworth Medical Centre and 63.8% at Irwell Medical Practice to 82.6% at Waterfoot Medical Practice. An unverified model projects 6,564 patients by 2030 (an increase of 835). Practice-level variation in blood pressure control may reflect differences in review pathways, suggesting scope to review recall protocols at lower-achieving practices.

    Lipids and statins

    Lipid-lowering therapy for QRISK ≥ 20% patients sits at 63.8% (England 63.6%), but three-year growth (+1.7%) lagged England (+6.2%). Prescribing of lipid-regulating drugs in adults (2,607 items per 1,000) also trails England (4,100). Slower growth in therapy initiation may reflect differences in cardiovascular risk review routines.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202665,424£1.50£1.64£1.86£98,136
    Cardiovascular (all), 202587,009£3.70£3.38£3.33£321,933

    In 2026, the PCN prescribed 65,424 lipid-regulating drug items at £1.50 per item (Rossendale £1.55, ICB £1.64, England £1.86), totaling £98,136, which is £23,553 less than at England's unit cost. Lower unit cost than England illustrates lower expenditure per item, though this indicator does not evaluate prescribing efficiency or clinical appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +4.14%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.60%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 3.2% (1,000 patients), above Rossendale (2.6%) and England (1.9%), with 82.5% receiving an annual review (England 76.4%). Asthma prevalence is 9.3% (2,769 patients; England 6.6%), and 1,664 asthma management items were prescribed per 1000 5-19 Population (England 1,488). While asthma reviews reached 68.0% (England 65.7%), an estimated 887 patients—about 890—remain without a recorded annual review.

    Cancer register and children's immunisation

    The cancer register records 1,306 patients (4.1% prevalence; England 3.8%). In Q1 2025/26 childhood immunisations, 6-in-1 coverage at 24 months reached 100.0% (denominator 56) and age-5 MMR1 reached 96.6% (denominator 87). However, age-5 coverage falls to 93.1% for MMR2 (1.9 pp below the 95.0% target) and 88.5% for 4-in-1 (6.5 pp below the target).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.9%

    England 91.0%

    6-in-1 complete primary course at 24 months100.0%

    England 92.2%

    MMR dose 1 at 24 months98.2%

    England 88.3%

    MMR dose 2 at age 593.1%

    England 82.8%

    4-in-1 pre-school booster at age 588.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of cancers with a known stage (4,642 of 8,863 staged cases; 74.6% known-stage share) in NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2, trailing England (55.3%) and below the 75.0% national ambition by 22.6 pp. The ICB early-stage share fell 1.2 pp from 2013 to 2022, requiring about 2,010 extra early-stage cases annually across the ICB. In the PCN, cervical screening reached 74.0% (England 66.8%) but fell 1.5% over 2023 to 2025 (England -1.0%). Maintaining proactive primary care screening recall is necessary to support early presentation before patients enter secondary diagnostic pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For East Lancashire Hospitals NHS Trust, July 2026 provisional data shows 73.2% of patients met the cancer 62-day treatment standard, below the 85.0% standard by 11.8 pp, while exceeding England (71.2%) and trailing Northern Care Alliance NHS Foundation Trust (78.6%) and the ICB (73.6%). The trust achieved the 28-day faster diagnosis standard at 81.5% (standard 75.0%; England 79.3%). Across all diagnostic tests, 3.2% waited 6+ weeks (England 23.1%), though cystoscopy waits reached 32.7% (England 24.4%). Robust primary care safety-netting is crucial while secondary treatment pathways experience 62-day delays.

    Pathways within standard (%)East LancashireNorthern Care AllianceBoltonLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)81.5075.2080.4878.3979.32
    31-day treatment (96%)98.1194.5496.5093.6292.50
    62-day referral to treatment (85%)73.1678.6569.6673.6271.16
    Diagnostic waits over 6 weeks (%)East LancashireNorthern Care AllianceBoltonEngland
    MRI0.435.092.0521.40
    CT0.154.1019.409.92
    Echocardiography0.0031.483.4828.48
    Colonoscopy0.9540.041.3330.83
    Gastroscopy1.1636.482.0629.02
    All 15 DM01 tests3.2515.7115.7823.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In June 2026 provisional experimental data, Lancashire residents recorded 293,090 community care activities, within 533,345 across NHS Lancashire and South Cumbria Integrated Care Board. Contacts with adults aged 65+ accounted for 56.9% of borough residents' community contacts (72,000 of 126,445). Linking community nursing into primary care palliative and cancer reviews can improve home-based support.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone ease varies by 25.7 pp across practices despite uniform overall good experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Waterfoot Medical10037.869.4%70.3%81.2%
    Irwell Medical10558.070.2%67.1%79.6%
    Whitworth1090.044.5%75.6%79.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNRossendaleAssetPCNRossendale
    Care homes (catchment)19 (463 beds)n/aSchools (catchment)43n/a
    Children's centres45Places of worship3244
    Libraries34Homelessness support (VCS)11
    Primary schools (LA maintained)1625Primary academies22
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Dementia register and care-home review

    Dementia prevalence is 0.7% (227 patients) vs 0.8% in Rossendale and England (19 to 26 benchmark patient gap), after falling 13.0% over 2023 to 2025 (England +6.0%). For discussion: audit clinical records across the 463 catchment care-home beds for unrecorded diagnoses and review memory-assessment referral pathways. Moderate effort to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Option 2

    Heart failure review and register audit

    Annual heart failure functional reviews reached 70.5% vs 75.1% in Rossendale and 78.5% in England (below England by 8.1 pp). The 308-patient register (1.0%) shows a -17 to +37 benchmark range. Moderate effort to run.

    Option 3

    Structured annual asthma review recall

    Asthma prevalence is 9.3% (2,769 patients vs 6.6% in England). Although annual reviews reached 68.0% (England 65.7%), an estimated 887 patients (about 890) had no recorded review. For discussion: combine annual asthma review invitations with repeat inhaler prescribing reviews and offer flexible or remote appointment slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 health outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Primary care telephony access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Dementia register and care-home review (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Option 2 · Heart failure review and register audit (p12)Heart failure register · Heart Failure: QOF prevalence · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)—PCN
    Option 3 · Structured annual asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15